340B: A program worth fighting for

Ted Slafsky and David L. Ramsey

Management in Healthcare: A Peer-Reviewed Journal, 2016, vol. 1, issue 3, 261-266

Abstract: The federal 340B drug discount program is essential to helping safety net providers meet their missions to treat the underserved. The program is under heavy attack in Washington, DC by the drug industry, which wants to gut it to maximise profits. At stake is US$4.5bn in savings that funds free/low-cost medicines for the needy and a panoply of clinical and pharmacy services to help uninsured and underinsured Americans. Strong advocacy from health providers is crucially needed to protect the 340B program. The authors present a strategy to clearly and publicly state the benefits of the program to the media and Congress.

Keywords: 340B; safety net hospital; drug discount (search for similar items in EconPapers)
JEL-codes: I1 I10 (search for similar items in EconPapers)
Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
https://hstalks.com/article/717/download/ (application/pdf)
https://hstalks.com/article/717/ (text/html)
Requires a paid subscription for full access.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aza:mih000:y:2016:v:1:i:3:p:261-266

Access Statistics for this article

More articles in Management in Healthcare: A Peer-Reviewed Journal from Henry Stewart Publications
Bibliographic data for series maintained by Henry Stewart Talks ().